Wepresent three elderly Japanese patients with abrupt onset of diabetes mellitus: a 61-yearold male with a complete defect of insulin secretion without insulin resistance, a 60-year-old male with an incomplete defect of insulin secretion associated with insulin resistance, and a 69-year-old female with a complete defect of insulin secretion and insulin resistance. The findings in these cases indicate the heterogeneity in insulin secretion and sensitivity of abrupt onset diabetes mellitus in the elderly. The changes in insulin secretion and sensitivity over time due to glucose toxicity may at least partially explain the heterogeneity. (Internal Medicine 34: 224-227, 1995) 
Introduction
Insulin-dependent diabetes mellitus (IDDM)is caused by a decrease in insulin secretion by the pancreas. Most such patients are young, and the disease onset is typically fairly rapid (1). Recently, Kobayashi et al (2) reported patients with onset of IDDMin middle age with a slow progression and the presence of islet cell autoantibodies (ICA). Takagi et al (3) reported IDDMwith onset in the elderly, and described Japanese cases whoseonset was acute or slowly progressive. They noted a considerable heterogeneity of the clinical features even within the acute onset group. Here, we present three cases of diabetes mellitus with abrupt onset in patients over 60 years of age and review the relevant Japanese literature.
Case Report
Case reports and review of the Japanese literature Case 1. A 61-year-old Japanese man developed polydipsia, nausea and vomiting on December23, 1991, and was admitted to KohokuHospital with a worsening of symptoms. He was 1 69 cm tall and weighed 50 kg. His blood pressure was normal (98/ 66 mmHg),and there was no diabetic retinopathy. There was no family history of diabetes. Results of a 75g oral glucose tolerance test performed 50 days prior to admission were normal. Laboratory data on admission revealed marked hyperglycemia (561 mg/dl) with ketoacidosis. The HbAlc level was 8.5% and C-peptide immunoreactivity (CPR) in urine was below the limit of detection. Islet cell surface antibody
controls (14 men and 4 women, mean age: 29.6 years) studied at our institution was 6.3±1.9 mg/kg/minute. The level of CPR in urine remained below the limit of detection, and examination by computed tomography and ultrasonography of the abdomen revealed no abnormalities. The patient was then discharged, and maintained on 0.56 units per kg insulin per day as an outpatient. Twenty-two months later, CPR remained undetectable in both serum and urine. Case 2. A 60-year-old Japanese man developed polydipsia and general malaise following an upper respiratory tract infection. His symptomsgrew worse, and he was admitted to Noichi Central Hospital on September 5, 1990. He was 163 cm tall and weighed 56 kg. His blood pressure was normal (1 30/72 mmHg) and there was no diabetic retinopathy. He denied a family history of diabetes, and his medical records showed no glycosuria on multiple urinalyses in the year before admission. Laboratory data on admission revealed hyperglycemia (804 mg/dl) without ketonuria and elevated serum levels of amylase (546 U/l) and of elastase I (1,210 ng/dl). CPR in urine was below the limit of detection. Both ICA and ICSA were not detectable. The administration of 22 units of regular insulin injected subcutaneously daily relieved the severe symptoms. However, the plasma glucose levels remained difficult to control over the next nine months, and the patient was readmitted on July 2, 199 1 for evaluation of 6-cell function and peripheral insulin resistance. Twenty-four months after disease onset, while the patient was receiving 0.67 units per kg of insulin per day, the fasting level of serum CPRwas 0.5 ng/ml and that 6 minutes after the intravenous administration of 1 mg of glucagon was 0.5 ng/ml. Eighteen diabetic patients with an abrupt onset after age 60 have been previously reported in the Japanese literature, in three articles (5-7) and 1 5 abstracts. A summary of their clinical features, including the three presented here, is shown in Fig. 1 while 7 cases had apartial defect. Eight of9 cases had DR4 and/ or DR9 in HLA. ICA was detected in 4 of 12 cases and ICSA was detected in 3 of 1 1 cases. Four of 19 cases had concomitant autoimmune disease. In addition, 5 cases had elevated pancreatic enzymes.
Discussion
Wepresented three elderly patients with diabetes of abrupt onset. They were all atypical for NIDDM as none were obese and had a family history of diabetes. The three cases had a complete insulin deficiency at presentation, which persisted in two cases. These findings support the diagnosis of IDDMin patients 1 and 3, while the absence of ketoacidosis and the finding of residual insulin secretion leaves the diagnosis of IDDMless certain in patient 2. Kilvert et al (8) reported elderly patients with the abrupt onset of diabetes, who were initially treated with insulin but were subsequently switched to receiving dietary and an oral hypoglycemic agent. Patient 2 in the present report had a complete defect in insulin secretion at onset, and showed a partial recovery nine months following onset. Thirty-six months following onset, he again showed a complete defect in insulin secretion. Eight of the 1 9 cases previously reported had a partial defect in insulin secretion, although onset was abrupt. Although insulin secretion was not evaluated on follow-up of these elderly onset diabetics, it seems clear from Kilvert's report, other previous reports and the present cases that insulin secretion may vary widely over time. Recently, there is evidence that the presence of hyperglycemia itself can lead to a deterioration of insulin secretion by the pancreas (9). Such glucose toxicity may contribute to the defect in insulin secretion on onset, and to the abrupt occurrence of symptomsin elderly people with diabetes.
Results of the hyperinsulinemic euglycemic clamp study revealed peripheral insulin resistance in patients 2 and 3.
However, the Mvalue in patient 1 was within normal range, revealing heterogeneity among these three patients. Insulin resistance is characteristic of patients with insulin-dependent diabeties with poor control of glycemia ( 10). Insulin resistance in the patients whose IDDMdeveloped at young age is thought to be due to an elevated production ofhepatic glucose ( 10) and/ or reduction in glucose uptake by skeletal muscle (1 1). Similar mechanismsmayhave contributed to the insulin resistance in patients 2 and 3. The reduction of insulin resistance by strict control of glycemia, exercise, and the continuous subcutaneous infusion of insulin has been reported (12). In addition, there is evidence that the presence of hyperglycemia itself can lead to a deterioration of insulin sensitivity (9). The difference in insulin resistance amongour patients mayexplain the difference in glycemic control. The changes in insulin secretion and resistance with time due to glucose toxicity may partially explain the heterogeneity. Further work is required to clarify the similarities and differences in the mechanismof insulin secretion and resistance in elderly vs young patients with IDDMas well as within the elderly patients with IDDM. The incidence of ICA and ICSA in Japanese patients with newly diagnosed IDDMexceeds 80% (13, 14) . In previous reports of elderly people with diabetes of abrupt onset, ICA was present in 4 of 12 patients (3, 5-7), while ICSA was present in 3 of ll patients (3, 5-7). Although the number of patients is small, the incidence of ICA and ICSA in elderly patients with diabetes of abrupt onset may be lower than that in young patients with IDDM.Two patients did not have ICA but had ICSA, while another two patients did not have ICSA but had ICA. No differences in HLAtype or in residual insulin secretion was observed between these patients (3, (5) (6) (7) . No patient has been reported to have both ICA and ICSA. No ICA was detected in the present cases. While patient 1 was positive for ICSA, it was not detected in patients 2 and 3. ICA and ICSA are autoantibodies for different antigens and have different effects on the pancreatic islet cells (15). The etiologic role ofICA and ICSA in elderly patients with diabetes of abrupt onset is unknown. It is noteworthy that our three elderly patients with abrupt onset diabetes and most of the previously reported cases had HLADR 4 and/or DR 9, both highly prevalent in young Japanese patients with IDDM(16). Finally, further study is required to clarify the pathogenesis of abrupt onset diabetes in the elderly. Accumulation of more cases of abrupt onset diabetes as well as long follow-up of insulin secretion and peripheral insulin resistance are needed. The evaluation of diabetes mellitus with abrupt onset in elderly patients is important for diagnosis and treatment.
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